Sydora Beate C, Tavernini Michele M, Doyle Jason, Fedorak Richard N
Center of Excellence for Gastrointestinal Inflammation and Immunity Research, Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Inflamm Bowel Dis. 2006 Aug;12(8):750-7. doi: 10.1097/00054725-200608000-00012.
Genetically induced disruption of the intestinal epithelial barrier leads to development of intestinal inflammation. In the interleukin-10 gene-deficient inflammatory bowel disease (IBD) mouse model, for instance, a primary defect in intestinal epithelial integrity occurs before the development of enterocolitis. In humans, a causal role for epithelial barrier disruption is still controversial. Although studies with first-degree relatives of IBD patients suggests an underlying role of impaired barrier function, a primary epithelial barrier defect in IBD patients has not been confirmed. The purpose of this article is to examine whether a primary epithelial barrier disruption is a prerequisite for the development of intestinal inflammation or whether intestinal inflammation can develop in the absence of epithelial disruption. We examined the intestinal epithelial integrity of the T cell receptor (TCR)-alpha gene-deficient mouse model of IBD.
In vivo colonic permeability, determined by mannitol transmural flux, was assessed in 6-week-, 12-week-, and 25-week-old TCR-alpha gene-deficient and wild-type control mice using a single-pass perfusion technique. Mice were scored for intestinal histological injury and intestinal cytokine levels measured in organ cultures. Systemic responses to bacterial antigens were determined through 48-h spleen cell cultures stimulated with sonicate derived from endogenous bacterial strains.
In contrast with previous findings in the interleukin-10 gene-deficient IBD model, TCR-alpha gene-deficient mice did not demonstrate evidence of primary intestinal epithelial barrier disruption at any age, despite developing a moderate to severe colitis within 12 weeks. A rise in intestinal interferon (IFN)-gamma levels preceded the onset of mucosal inflammation and then correlated closely with the degree of intestinal inflammation and injury. Spleen cells from TCR-alpha gene-deficient mice released IFN-gamma in response to stimulation with endogenous luminal bacterial antigens, a finding that suggests that the systemic response to bacterial antigens occurred independently of epithelial barrier disruption.
Intestinal inflammation and a systemic response to bacterial antigens can develop in the absence of a measurable disruption of intestinal permeability.
基因诱导的肠道上皮屏障破坏会导致肠道炎症的发生。例如,在白细胞介素-10基因缺陷型炎症性肠病(IBD)小鼠模型中,肠道上皮完整性的原发性缺陷在小肠结肠炎发展之前就已出现。在人类中,上皮屏障破坏的因果作用仍存在争议。尽管对IBD患者一级亲属的研究表明屏障功能受损具有潜在作用,但IBD患者的原发性上皮屏障缺陷尚未得到证实。本文的目的是研究原发性上皮屏障破坏是否是肠道炎症发生的先决条件,或者肠道炎症是否能在无上皮破坏的情况下发生。我们研究了IBD的T细胞受体(TCR)-α基因缺陷小鼠模型的肠道上皮完整性。
使用单通道灌注技术,在6周龄、12周龄和25周龄的TCR-α基因缺陷小鼠和野生型对照小鼠中,通过甘露醇跨壁通量评估体内结肠通透性。对小鼠的肠道组织学损伤进行评分,并在器官培养物中测量肠道细胞因子水平。通过用源自内源性细菌菌株的超声裂解物刺激48小时的脾细胞培养物,确定对细菌抗原的全身反应。
与白细胞介素-10基因缺陷型IBD模型的先前研究结果相反,TCR-α基因缺陷小鼠在任何年龄均未表现出原发性肠道上皮屏障破坏的证据,尽管在12周内发展为中度至重度结肠炎。肠道干扰素(IFN)-γ水平在黏膜炎症发作之前升高,然后与肠道炎症和损伤程度密切相关。TCR-α基因缺陷小鼠的脾细胞在受到内源性肠腔细菌抗原刺激后释放IFN-γ,这一发现表明对细菌抗原的全身反应独立于上皮屏障破坏而发生。
在肠道通透性无明显破坏的情况下,可发生肠道炎症和对细菌抗原的全身反应。